EOFlow
Seongnam · Founded 2011
About EOFlow
EOFlow has launched EOPatch, the world’s smallest full-featured wearable, disposable insulin pump. EOPatch wearable insulin pump is smarter, better-connected, and lasts longer than the current market leader, yet costs less. The company will offer a software upgrade to enable closed-loop insulin control ('artificial pancreas' or 'automated insulin delivery') on the current system. It is also developing an all-in-one wearable disposable artificial pancreas solution, which was recently given a Breakthrough Device designation by FDA.
Company Facts
- Founded: 2011
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $28.0M
- Funding stage: IPO
- Last round: Series D (Feb 2019)
- Ticker: kosdaq:294090
- Website: eoflow.com
- Phone: +82-31-738-0200
Industries & Categories
Health Care, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/eoflow-141808 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.